TrialAntimicrobial agents and chemotherapy2000

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.

C W Hendrix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.